These medications work through multiple mechanismsreducing appetite, slowing digestion, and affecting brain hunger centersproducing weight loss results that were previously only achievable through bariatric surgery
In patients in whom the above-mentioned interventions are insufficient to control the manifestations of HF, additional mechanical circulatory support and/or cardiac transplantation may be indicated
Additionally, a 3-year prospective study involving 1274 patients with modestly controlled T2DM reported that treatment with dapagliflozin or canagliflozin was linked to significant neuroprotective effects
That approach can fail when hunger hormones, cravings, stress, sleep disruption, insulin resistance, or metabolic adaptation push the body back toward weight regain
Shauna Levy of the Tulane Weight Loss Center noted that strict timing requirements could impact real-world results
In turn, telehealth companies began selling the drugs at prices far lower than the average $1,300 per month paid for brand-name GLP-1s
